Top Section/Ad
Top Section/Ad
Most recent
Cell and gene therapy company plans US expansion
More articles/Ad
More articles/Ad
More articles
-
Recoveries of bank share prices and the block market are welcome signs for European bank privatisations -
LSEG’s £2.65bn selldown has kick-started the market as the rest of ECM stutters
-
Alongside a £30m placing, there is a £3m retail offer via REX
-
The lock-up from the last sale in March was waived early, paving the way for another giant LSEG block
-
The €200m share sale is the first time Azelis has raised fresh capital since its IPO in 2021
-
In a block trade, GSK sold 2.6% of its former joint venture with Pfizer
